PLATELET MICROPARTICLES IN IMMUNE THROMBOCYTOPENIC PURPURA IN PEDIATRICS

REFERENCES

• Ozsoylu S. Every immune thrombocytopenia is not idiopathic thrombocytopenic purpura. Acta Paediatr. 2004;93:1129–1130.
   Web of Science ®Google Scholar
• Medeiros D, Buchanan GR. Idiopathic thrombocytopenic purpura. Curr Opin Pediatr. 2000;12:4–9.
   PubMed Web of Science ®Google Scholar
• George JN, Raskob GE. Idiopathic thrombocytopenic purpura: a concise summary of the pathophysiology and diagnosis in children and adults. Semin Hematol. 1998;35:5–8.
   PubMed Web of Science ®Google Scholar
• Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood. 2007;21:157–171.
   Google Scholar
• Horstman LL, Jy W, Jimenez JJ, . New Horizons in the analysis of circulating cell-derived microparticles. Keio J Med. 2004;53:210–230.
   PubMedGoogle Scholar
• Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol. 1967;13:269–288.
   PubMed Web of Science ®Google Scholar
• Polasek J. The appearance of multivesicular structures during platelet activation as observed by scanning electron microscopy. Thromb Res. 1982;28:433–437.
   Google Scholar
• George JN, Thoi LL, McManus LM, Reimann TA. Isolation of human platelet membrane microparticles from plasma and serum. Blood. 1982;60:834–840.
   PubMed Web of Science ®Google Scholar
• Flaumenhaft R. Formation and fate of platelet microparticles. Blood Cells Mol Dis. 2006;36:182–187.
   PubMed Web of Science ®Google Scholar
• Horstman LL, Valle-Riestra BJ, Jy W, . Desmorpressin (DDAVP) acts on platelets to generate platelet microparticles and enhanced procoagulant activity. Thromb Res. 1995;79:163–174.
   PubMed Web of Science ®Google Scholar
• Siddiqui FA, Desai H, Amirkhosravi A, . Platelet microparticles from healthy donors contain tissue factor (Abstract). Blood. 2002;100: 497a#1936.
   Google Scholar
• Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost. 2003;1:1897–1905.
   PubMed Web of Science ®Google Scholar
• Jy W, Horstman LL, Arce M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenia. J Lab Clin Med. 1992;119:334–345.
   PubMed Web of Science ®Google Scholar
• Page LK, Psaila B, Provan D, . The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP. Br J Haematol. 2007;138:245–248.
   PubMed Web of Science ®Google Scholar
• Shet AS, Aras O, Gupta K, . Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood. 2003;102:2678–2683.
   PubMed Web of Science ®Google Scholar
• Laffan M, Manning R. Investigations of haemostasis. In: Lewis SM, Bain BJ, Bates I, eds. Dacie and Lewis Practical Haematology. 10th ed. Churchill Livingstone Elsevier; 2006:392.
   Google Scholar
• Nieuwland R, Berckmans RJ, McGregor S, . Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood. 2000;95:930–935.
   PubMed Web of Science ®Google Scholar
• Diamant M, Nieuwland R, Pablo RF, . Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation. 2002;106:2442–2447.
   PubMed Web of Science ®Google Scholar
• Berckmans RJ, Neiuwland R, Böing AN, . Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost. 2001;85:639–646.
   PubMed Web of Science ®Google Scholar
• Zucker-Franklin D, Karpatkin S. Red cell and platelet fragmentation in idiopathic autoimmune thrombocytopenic purpura. N Engl J Med. 1977;297:517–523.
   PubMed Web of Science ®Google Scholar
• Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet derived microparticles in humans. Blood. 1990;75:128–138.
   PubMed Web of Science ®Google Scholar
• Bode AP, Orton SM, Frye MJ, Udis BJ. Vesiculation of platelets during in vitro aging. Blood. 1991;77:887–895.
   PubMed Web of Science ®Google Scholar
• Ahn YS, Horstman LL, Jy W, . Vascular dementia in patients with immune thrombocytopenic purpura. Thromb Res. 2002;107:337–344.
   PubMed Web of Science ®Google Scholar
• Ahn YS, Horstman LL. Idiopathic thrombocytopenic purpura: pathophysiology and management. Int J Hematol. 2002;76(Suppl 2):123–131.
   Google Scholar
• Theeler BJ, Ney JP. A patient with idiopathic thrombocytopenic purpura presented with an acute ischemic stroke. J Stroke Cerebrovascular Dis. 2008;17:244–245.
   Google Scholar
• Tiede MP, Ahn ER, Jy W, . Life-threatening hypercoagulable state following splenectomy in ITP: successful management with aggressive antithrombotic therapy and danazol. Clin Appl Thromb Hemostat. 2005;11:347–352.
   PubMedGoogle Scholar
• Fontana V, Jy W, Ahn ER, . Increased procoagulant cell-derived microparticles (C-MP) in splenectomized patients with ITP. Thromb Res. 2008;122:599–603.
   PubMed Web of Science ®Google Scholar